HR POSITIVE HER2 NEGATIVE ADVANCED BREAST CANCER
Clinical trials for HR POSITIVE HER2 NEGATIVE ADVANCED BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new HR POSITIVE HER2 NEGATIVE ADVANCED BREAST CANCER trials appear
Sign up with your email to follow new studies for HR POSITIVE HER2 NEGATIVE ADVANCED BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo trial offers hope for advanced breast cancer patients
Disease control Recruiting nowThis study is testing two different doses of a drug called dalpicicl when combined with letrozole for people with advanced HR-positive, HER2-negative breast cancer. The trial will enroll 120 participants who haven't received prior treatment for their advanced cancer to see which …
Matched conditions: HR POSITIVE HER2 NEGATIVE ADVANCED BREAST CANCER
Phase: PHASE2 • Sponsor: wanghaibo • Aim: Disease control
Last updated Apr 04, 2026 00:35 UTC
-
First human trial launches for experimental cancer 'Breaker' drug
Disease control Recruiting nowThis is the first human study testing a new experimental drug called BBO-10203 in people with advanced solid tumors that have spread or cannot be removed by surgery. The main goal is to find safe doses and see how the body processes the drug, both alone and when combined with oth…
Matched conditions: HR POSITIVE HER2 NEGATIVE ADVANCED BREAST CANCER
Phase: PHASE1 • Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC